Restoring expression of Stathmin-2: a novel strategy to treat TDP-43 proteinopathies

Signal Transduct Target Ther. 2023 Jul 12;8(1):266. doi: 10.1038/s41392-023-01533-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Stathmin* / genetics
  • TDP-43 Proteinopathies*

Substances

  • Stathmin